Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Submitted by
admin
on August 27, 2012 - 5:27pm
Source:
Seeking Alpha
News Tags:
Amylin
M&A
Bristol-Myers Squibb
Merck
Eli Lilly
AstraZeneca
diabetes
Headline:
Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Do Not Allow Advertisers to Use My Personal information
